BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 36473391)

  • 21. [Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].
    Feist H; Blöcker T; Hussein K
    Pathologe; 2015 Jul; 36(4):355-61. PubMed ID: 25613921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?
    Brady CA; Williams C; Sharps MC; Shelleh A; Batra G; Heazell AEP; Crocker IP
    Am J Reprod Immunol; 2021 Mar; 85(3):e13373. PubMed ID: 33155353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Massive perivillous fibrin deposition: Diagnosis, obstetrical features, and treatment.
    Cheloufi M; Coulomb A; Abisror N; Kayem G; Fain O; Alijotas-Reig J; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():125-132. PubMed ID: 37995528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathology of the placenta. VI. Circulation disorders of the placenta. Maternal circulation (intervillous space)].
    Emmrich P
    Zentralbl Pathol; 1991; 137(4):316-24. PubMed ID: 1768682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of placental-derived fetal growth restriction.
    Burton GJ; Jauniaux E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes.
    Bouariu A; Gică N; Ciobanu AM; Scutelnicu AM; Popescu MR; Panaitescu AM
    Healthcare (Basel); 2022 Jan; 10(1):. PubMed ID: 35052331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Placental features in intrauterine growth retardation].
    Marcorelles P
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):996-1007. PubMed ID: 24210718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental pathologic lesions with a significant recurrence risk - what not to miss!
    Chen A; Roberts DJ
    APMIS; 2018 Jul; 126(7):589-601. PubMed ID: 29271494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth Restriction, Osteopenia, Placental Massive Perivillous Fibrin Deposition With (or Without) Intervillous Histiocytes and Renal Tubular Dysgenesis-An Emerging Complex.
    Abdulghani S; Moretti F; Nikkels PG; Khung-Savatovsky S; Hurteau-Miller J; Grynspan D
    Pediatr Dev Pathol; 2018; 21(1):91-94. PubMed ID: 29187034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The severity of chronic histiocytic intervillositis is associated with gestational age and fetal weight.
    Bos M; Koenders MJM; Dijkstra KL; van der Meeren LE; Nikkels PGJ; Bloemenkamp KWM; Eikmans M; Baelde HJ; van der Hoorn MLP
    Placenta; 2023 Jan; 131():28-35. PubMed ID: 36473391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.
    Cornish EF; McDonnell T; Williams DJ
    Front Immunol; 2022; 13():825075. PubMed ID: 35529853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent Chronic Intervillositis: The Diagnostic Challenge - A Case Report and Review of the Literature.
    Hannaford P; Mittal N; Sethna F; Dahlstrom JE
    J Obstet Gynaecol Can; 2019 Mar; 41(3):344-347. PubMed ID: 30414807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review.
    Bos M; Nikkels PGJ; Cohen D; Schoones JW; Bloemenkamp KWM; Bruijn JA; Baelde HJ; van der Hoorn MLP; Turner RJ
    Placenta; 2018 Jan; 61():80-88. PubMed ID: 29277275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.
    Schwartz DA; Morotti D
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33203131
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.